(Q40401691)

English

Treatment of experimental hepatic fibrosis by combinational delivery of urokinase-type plasminogen activator and hepatocyte growth factor genes

scientific article published on August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 September 2017

Treatment of experimental hepatic fibrosis by combinational delivery of urokinase-type plasminogen activator and hepatocyte growth factor genes (English)

1 reference

Europe PubMed Central

20 September 2017

author name string

Yong Lin

1

1 reference

Europe PubMed Central

20 September 2017

Wei-Fen Xie

2

1 reference

Europe PubMed Central

20 September 2017

Yue-Xiang Chen

3

1 reference

Europe PubMed Central

20 September 2017

Xin Zhang

4

1 reference

Europe PubMed Central

20 September 2017

Xin Zeng

5

1 reference

Europe PubMed Central

20 September 2017

Hui Qiang

6

1 reference

Europe PubMed Central

20 September 2017

Wei-Zhong Chen

7

1 reference

Europe PubMed Central

20 September 2017

Xiu-Jiang Yang

8

1 reference

Europe PubMed Central

20 September 2017

Ze-Guang Han

9

1 reference

Europe PubMed Central

20 September 2017

Zhong-Bing Zhang

10

1 reference

Europe PubMed Central

20 September 2017

publication date

1 August 2005

1 reference

Europe PubMed Central

20 September 2017

Liver International

1 reference

Europe PubMed Central

20 September 2017

25

1 reference

Europe PubMed Central

20 September 2017

4

1 reference

Europe PubMed Central

20 September 2017

796-807

1 reference

Europe PubMed Central

20 September 2017

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01098.X

21 January 2018

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01098.X

21 January 2018

Gene therapy for hepatic fibrosis-bringing treatment into the new millennium

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01098.X

21 January 2018

Gene therapy of hepatic diseases: prospects for the new millennium

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01098.X

21 January 2018

Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01098.X

21 January 2018

Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01098.X

21 January 2018

Hepatocyte growth factor: a multifunctional cytokine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01098.X

21 January 2018

Hepatocyte growth factor gene therapy of liver cirrhosis in rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01098.X

21 January 2018

Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01098.X

21 January 2018

Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01098.X

21 January 2018

A simplified system for generating recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01098.X

21 January 2018

The fine structure, potassium content, and respiratory activity of isolated rat liver parenchymal cells prepared by improved enzymatic techniques

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01098.X

21 January 2018

Rapid assay of HSF1 and HSF2 gene expression by RT-PCR.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01098.X

21 January 2018

Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01098.X

21 January 2018

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01098.X

21 January 2018

Assessment of efficiency and safety of adenovirus mediated gene transfer into normal and damaged murine livers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01098.X

21 January 2018

Hepatocyte growth factor gene transfer into the liver via the portal vein using electroporation attenuates rat liver cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01098.X

21 January 2018

Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01098.X

21 January 2018

Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1beta converting enzyme cDNA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01098.X

21 January 2018

Identifiers

10.1111/J.1478-3231.2005.01098.X

1 reference

Europe PubMed Central

20 September 2017

1 reference

Europe PubMed Central

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40401691&oldid=1896942602"